| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/10717544.2018.1451572 |
| P8608 | Fatcat ID | release_c25tf24dtjai3dhix7vy3g7eqq |
| P932 | PMC publication ID | 6058680 |
| P698 | PubMed publication ID | 29557244 |
| P2093 | author name string | Aly A Abdelbary | |
| Abdelhalim I Elassasy | |||
| Diana E Aziz | |||
| P2860 | cites work | Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment | Q88168426 |
| Studies on a high encapsulation of colchicine by a niosome system | Q44120610 | ||
| Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes | Q44535617 | ||
| Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. | Q45110091 | ||
| Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment | Q46217154 | ||
| Brain delivery of olanzapine by intranasal administration of transfersomal vesicles. | Q46358000 | ||
| Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain | Q46489252 | ||
| Studies on synthesis, stability, release and pharmacodynamic profile of a novel diacerein-thymol prodrug | Q46526232 | ||
| Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease | Q46740678 | ||
| Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study | Q46833056 | ||
| A new approach for the evaluation of niosomes as effective transdermal drug delivery systems | Q48154887 | ||
| Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study | Q49887046 | ||
| Long-circulating lipoprotein-mimic nanoparticles for smart intravenous delivery of a practically-insoluble antineoplastic drug: Development, preliminary safety evaluations and preclinical pharmacokinetic studies. | Q53387224 | ||
| Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery. | Q53799601 | ||
| Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study | Q81546003 | ||
| Spanlastics--a novel nanovesicular carrier system for ocular delivery | Q84026987 | ||
| Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes | Q86833321 | ||
| In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers | Q30581314 | ||
| Multiple level C in vitro/in vivo correlation of dissolution profiles of two L-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism. | Q30919520 | ||
| Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties | Q31552086 | ||
| Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. | Q33800631 | ||
| Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam | Q35583139 | ||
| Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation | Q35635404 | ||
| Status of surfactants as penetration enhancers in transdermal drug delivery. | Q35770434 | ||
| Nanoethosomal transdermal delivery of vardenafil for treatment of erectile dysfunction: optimization, characterization, and in vivo evaluation | Q35851963 | ||
| Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis | Q36128845 | ||
| Chondroprotective drugs in degenerative joint diseases | Q36309644 | ||
| Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation | Q36852078 | ||
| Transdermal delivery of calcium channel blockers for hypertension | Q38092853 | ||
| Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects | Q39224874 | ||
| A novel nanovesicular carrier system to deliver drug topically | Q39345301 | ||
| Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes | Q39520026 | ||
| Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers | Q41835839 | ||
| A stability-indicating high performance liquid chromatographic method for the determination of diacerein in capsules | Q42045764 | ||
| Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats | Q42398274 | ||
| Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery | Q42990363 | ||
| Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements | Q43568216 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | statistics | Q12483 |
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 815-826 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | Drug Delivery | Q5308838 |
| P1476 | title | Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. | |
| P478 | volume | 25 |
Search more.